1. P.E.C. Manson-Bahr, East African kala-azar with special reference to the pathology, Prophylaxis and treatment, Trans. R. Soc.Trop.Med.Hyg., 53:123 (1959).
2. J.Alvar, Leishmaniasis-AIDS association: new epidemiological perspectives (this volume).
3. D.L. Sacks, S.L. Lal, S.N. Shrivastava, J. Blackwell and F. Neva, An analysis of T cell responsiveness in Indian Kala-azar, J.Immunol., 138:908 (1987)
4. K.C.Carter, A.J.Baillie, J.Alexander and T.F.Dolan, Clearance of L.donovani from the liver of BALB/c mice results in local resistance to re-infection, (this volume).
5. L.E. Adinolfi, P.F. Bonventre, M. Vander Pas and D.A. Eppstein, Synergistic effect of Glucantime and Liposome-Encapsulated Muramyl Dipeptide analog in the therapy of Experimental Visceral Leishmaniasis, Infec.Immun., 48:409 (1985).